Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for alopecia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Apr 2026: Trial started, NCT07693244
  2. 9 Jul 2026: Trial registered, NCT07693244

The trials

NCT07693244: Exosome Therapy for Male Androgenetic Alopecia

State
Under way
Phase
Phase 2
People
120 planned
Started
30 Apr 2026
Primary completion
10 Nov 2026
Arms
hUCMSC-Exosome Injection
Results
None posted
  1. 30 Apr 2026: Trial started
  2. 9 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.